Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Ann Nutr Metab ; 61(3): 236-8, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23183295

RESUMEN

In the 1930s, Rudolf Peters showed that young rats kept on a semi-synthetic diet with added thiamin and riboflavin but no other supplement developed 'rat acrodynia', a condition characterized by severe cutaneous lesions. In 1934, Paul György showed that the factor which cured 'rat acrodynia' was vitamin B(6). Other studies soon showed that vitamin B(6) deficiency produced convulsions in rats, pigs, and dogs, and a microcytic anemia in certain animals. Samuel Lepkovsky isolated and crystallized vitamin B(6) in 1938. The following year, Leslie Harris and Karl Folkers, and Richard Kuhn and his associates independently showed that vitamin B(6) was a pyridine derivative, 3-hydroxy-4,5-dihydroxy-methyl-2-methyl-pyridine. György proposed the term pyridoxine for this derivative. Esmond Snell developed a microbiological growth assay in 1942 that led to the characterization of pyridoxamine, the animated product of pyridoxine, and pyridoxal, the formyl derivative of pyridoxine. Further studies showed that pyridoxal, pyridoxamine, and pyridoxine have largely equal activity in animals and owe their vitamin activity to the ability of the organism to convert them into the enzymatically active form pyridoxal-5-phosphate. Pyridoxal-5-phosphate plays a role in a wide variety of enzyme systems, especially in the metabolic utilization and transformation of amino acids.


Asunto(s)
Vitamina B 6/química , Vitamina B 6/historia , Vitamina B 6/aislamiento & purificación , Vitamina B 6/farmacología , Animales , Perros , Historia del Siglo XX , Fosfato de Piridoxal/metabolismo , Piridoxamina/metabolismo , Piridoxina/metabolismo , Ratas , Porcinos , Deficiencia de Vitamina B 6/tratamiento farmacológico , Deficiencia de Vitamina B 6/fisiopatología , Vitaminas/metabolismo
2.
J Biochem ; 147(4): 451-7, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20353954

RESUMEN

Esmond E. Snell (1914-2003) was a giant of B-vitamin and enzyme research. His early research in bacterial nutrition had lead to the discovery of vitamins such as lipoic acid and folic acid, and an anti-vitamin avidin. He developed microbiological assay methods for riboflavin and other vitamins and amino acids, which are still used today. He also investigated the metabolism of vitamins, discovered pyridoxal and pyridoxamine as the active forms of vitamin B(6) and revealed the mechanism of transamination and other reactions catalysed by vitamin B(6) enzymes. His research in later years on pyruvoyl-dependent histidine decarboxylase unveiled the biogenesis mechanism of this first built-in cofactor. Throughout his career, he was a great mentor of many people, all of whom are inspired by his philosophy of science.


Asunto(s)
Coenzimas/historia , Complejo Vitamínico B/historia , Animales , Arthrobacter/enzimología , Arthrobacter/metabolismo , Bioquímica/historia , Coenzimas/aislamiento & purificación , Coenzimas/fisiología , Historia del Siglo XX , Humanos , Lactobacillus/enzimología , Lactobacillus/crecimiento & desarrollo , Lactobacillus/metabolismo , Técnicas Microbiológicas/historia , Ácido Pantoténico/aislamiento & purificación , Ácido Pantoténico/fisiología , Pseudomonas/enzimología , Pseudomonas/metabolismo , Saccharomyces/enzimología , Saccharomyces/crecimiento & desarrollo , Saccharomyces/metabolismo , Vitamina B 6/historia , Vitamina B 6/aislamiento & purificación , Vitamina B 6/fisiología , Complejo Vitamínico B/aislamiento & purificación , Complejo Vitamínico B/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA